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In T cell–dependent B cell responses, activated 
B cells migrate into the B cell follicles where they 
proliferate, with a fraction of cells undergoing 
Ig class switch recombination (CSR; Coffey 
et al., 2009; Pereira et al., 2010). Although some 
of the activated cells mediate the primary anti-
body response through differentiation into plasma 
cells, others are recruited into the germinal center 
(GC) reaction (Pereira et al., 2010). This is ac-
companied by up-regulation of the transcrip-
tional repressor Bcl6, on which GC B cell 
differentiation depends (Dent et al., 1997; Ye 
et al., 1997). Bcl6 up-regulation is also required 
for the differentiation of follicular (FO) T helper 
(Tfh) cells. These cells are critical for the selec-
tion of B cells expressing high-affinity antibodies 
in the GC environment (Crotty, 2011).
Within the GC, B cells undergo massive pro-
liferation accompanied by CSR and somatic 
hypermutation (SHM) of their rearranged Ig V 
region genes, a process in which cells prefer-
entially survive which have acquired mutations 
that increase antibody affinity for the immunizing 
antigen (Rajewsky, 1996). This selection pro-
cess critically depends on antigen presented to 
the B cells by FO DCs in the GC microenvi-
ronment and, in turn, presented by the B cells 
in the form of antigenic peptides to antigen-
specific Tfh cells, resulting in the delivery of 
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One component of memory in the antibody system is long-lived memory B cells selected for the 
expression of somatically mutated, high-affinity antibodies in the T cell–dependent germinal 
center (GC) reaction. A puzzling observation has been that the memory B cell compartment also 
contains cells expressing unmutated, low-affinity antibodies. Using conditional Bcl6 ablation, 
we demonstrate that these cells are generated through proliferative expansion early after 
immunization in a T cell–dependent but GC-independent manner. They soon become resting and 
long-lived and display a novel distinct gene expression signature which distinguishes memory  
B cells from other classes of B cells. GC-independent memory B cells are later joined by somati-
cally mutated GC descendants at roughly equal proportions and these two types of memory cells 
efficiently generate adoptive secondary antibody responses. Deletion of T follicular helper (Tfh) 
cells significantly reduces the generation of mutated, but not unmutated, memory cells early on 
in the response. Thus, B cell memory is generated along two fundamentally distinct cellular 
differentiation pathways. One pathway is dedicated to the generation of high-affinity somatic 
antibody mutants, whereas the other preserves germ line antibody specificities and may prepare 
the organism for rapid responses to antigenic variants of the invading pathogen.
© 2012 Kaji et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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Figure 1.  Targeted insertion of loxP sites into the Bcl6 gene. (A). A DNA fragment which contains exons 7–9 of the Bcl6 gene was flanked by loxP sites 
(solid triangles) with an FRT-flanked pGK-Neo cassette inserted next to it. The pGK-Neo cassette was removed from the mouse germline by breeding heterozy-
gous mice to FLPe-expressing deleter mice. Xb, XbaI site; Hd, HindIII site. (B) Southern blot analysis of XbaI digested genomic DNA from a WT and a targeted ES 
clone using the probe depicted by the thick bar in A. (C) Removal of the pGK-Neo cassette in a heterozygous floxed mouse was confirmed by genomic PCR. 
Location of the primer set is indicated by the two arrowheads on the bottom of A. (D–G) Bcl6flox mice were crossed to mb1-cre mice. Conditional Bcl6-deletion 
in B cells does not affect BM B cell development (D), B cell numbers in the spleen (E), and B cell characteristics before immunization (F and G). BM cells and 
splenocytes were prepared from Bcl6+/+ (+/+), Bcl6+/f (+/f), and Bcl6f/f (f/f) mice heterozygous for mb1-cre (n = 3). The frequency of B cell subsets in BM (D) and 
T and B cells in the spleen (E) was analyzed by FACS. Each symbol represents the number of cells in an individual mouse. Bars represent the mean number for JEM Vol. 209, No. 11 
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survival signals for the B cells involved (Victora et al., 2010). 
The selected high-affinity GC cells are then believed to dif-
ferentiate into memory B and long-lived plasma cells, a large 
fraction of which express somatically mutated Ig V region 
genes and which persist for long periods of time after termina-
tion of the GC response (Rajewsky, 1996; Tarlinton, 2006).
Although the precursor-product relationship of GC and 
memory B cells seems firmly established, a puzzling observa-
tion has been that not all memory B cells carry somatic muta-
tions in their Ig V regions (Takahashi et al., 2001; Blink et al., 
2005; Anderson et al., 2007; Zotos et al., 2010). In addition, 
ICOS blockade early in the immune response caused a re-
duction in the frequency of mutated memory and GC B cells 
but did not affect total memory B cell numbers (Inamine 
et al., 2005). These findings led to the view that some memory 
cells emerge from the early GC reaction (Good-Jacobson and 
Shlomchik, 2010) or may even be GC independent, as un-
mutated memory cells can be generated in irradiated mice 
reconstituted with Bcl6-deficient BM (Toyama et al., 2002).
However, Bcl6 germline deletion causes multiple immuno-
logical dysfunctions, such as arrested Tfh and conventional 
DC development (Crotty, 2011; Ohtsuka et al., 2011), as 
well as aberrant macrophage function (Mondal et al., 2010). 
Furthermore, Bcl6 germline deletion causes a prominent in-
flammatory disease owing to overexpression of Th2 cytokines 
(Ye et al., 1997; Dent et al., 1997) and affects the properties of 
B cells before immunization (Shaffer et al., 2000). Thus, there 
is no evidence for a GC-independent pathway of memory 
cell  generation  under  physiological  conditions.  Moreover, 
even if such a pathway exists, its timing in the response and 
impact on B cell memory, and the properties of the partici-
pating cells remain elusive.
To obtain a comprehensive understanding of the popula-
tion dynamics underlying GC-independent and -dependent 
memory B cell development under physiological conditions, 
we deleted Bcl6 in the B or T cell lineage through a con-
ditional Bcl6 allele and complemented these experiments by 
antibody-mediated ablation of the GC response in genetically 
intact animals. Focusing on antigen-specific IgG1-expressing 
memory cells, which can be conveniently isolated and distin-
guished from GC B cells by the level of CD38 expression 
(Ridderstad and Tarlinton, 1998; Takahashi et al., 2001), we 
then pursued the fate of these cells in the T cell–dependent 
immune response and characterized their properties, genetic 
signature, life span, and functional activity.
Our work not only provides definitive evidence for a GC-
independent  pathway  of  memory  cell  generation  under 
physiological conditions but also a comprehensive view of 
the strikingly distinct population dynamics underlying GC-
independent and -dependent memory B cell development with 
the help of distinct T cell subsets. The two classes of memory 
cells establish the memory compartment jointly and at com-
parable frequencies and attain functional maturation through 
distinct though related transcriptional programs.
RESULTS
Bcl6 deletion in B cells impairs GC but not memory  
B cell development
We established mutant mice carrying a loxP-flanked Bcl6 exon 
7–9 allele (Bcl6f/f), with these exons encoding the Bcl6 zinc 
finger (ZF) domains ZF1 to ZF5 (Fig. 1). As the ZF domains 
are critical for Bcl6 function (Basso and Dalla-Favera, 2010), 
deletion of exons 7–9 is predicted to cause a complete loss of 
the capacity of Bcl6 to repress transcription of target genes.
Whereas mice with Bcl6 deletion in the germline exhibit 
aberrant B cell development in the BM and an activated pheno-
type in naive splenic B cells (Shaffer et al., 2000; Duy et al., 
2010), the conditional deletion of Bcl6 in B cells had no effect 
on B cell numbers, phenotype, or cytokine production after 
stimulation through the B cell receptor or Toll-like receptor 
(Fig. 1). To dissect IgG1 memory B cell development, Bcl6f/f 
mice were crossed with mice in which a cre cDNA is knocked 
into the C1 locus (C1-cre; Casola et al., 2006). We immu-
nized the compound mutants and control mice with chicken 
-globulin (CG) coupled to (4-hydroxy-3-nitrophenyl)acetyl 
(NP-CG) and tracked NP-specific/IgG1+ memory (CD38+/
peanut agglutinin [PNA]low) and GC (CD38low/PNA+) B cells 
in the spleen of immunized mice by multicolor flow cytome-
try (Fig. S1; Takahashi et al., 2001). GC reactions have been 
reported to persist for a long time after immunization (Dogan 
et al., 2009). Indeed, we found that approximately one fourth 
of the NP-specific/IgG1 B cells consisted of GC B cells 150 d 
after immunization (Fig. S1).
Bcl6 protein expression is limited to the GC stage of B cell 
differentiation (Basso and Dalla-Favera, 2010). Bcl6 was brightly 
stained in the nuclei of PNAhigh/CD38+ and CD38dull B cells 
at day 7 after immunization, supporting the notion that the 
transition of GC B cells from a CD38high to a CD38dull pheno-
type occurs early in the immune response (Shinall et al., 
2000). Contrarily, Bcl6 was not detected in the nucleus of 
WT memory B cells (unpublished data). The conditional de-
letion of Bcl6 reduced the number of NP-specific/IgG1+ GC 
B cells in the spleen at days 7 and 40 after immunization to 
<2% of controls (Fig. 2 A). Early GC B cells were also deleted 
in the mutant mice (unpublished data). In striking contrast, 
the number of memory B cells was unaffected. These results 
suggest that Bcl6 expression in B cells is essential for GC but 
not memory B cell development.
To confirm this possibility, we crossed the Bcl6f/f mice 
with mice expressing Cre recombinase from the mb-1 locus 
and thus from early on in B cell development (Hobeika et al., 
2006). Cre-mediated recombination in WT mice was detected 
each group. (F) Representative FACS plots of splenic B cells with expression of CD44 and CD69 (activated B cell phenotype). Numbers in the plots indicate the 
percentage of cells in quadrants. (G) The levels of cytokines in culture supernatants produced by splenic B cells upon stimulation with anti-IgM and anti-CD40 
mAb or LPS for 3 d (see Materials and methods). Bars represent means for each group. The data are representative of two independent experiments in D–G.
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Figure 2.  IgG1+ memory B cells develop independently of the GC reaction. Splenocytes were recovered from Bcl6+/+, Bcl6+/f, and Bcl6f/f 
mice heterozygous for C1-cre (A) or mb1-cre (B) at day 7 or 40 after immunization with NP-CG in alum and NP-specific/IgG1+ memory and GC  
B cells were enumerated from 106 cells within the lymphocyte gate (see Materials and methods). Circles represent the number of cells in individual 
mice (n = 3–5). Bars indicate the mean number in each group. (C) BM cells from Bcl6f/f mice heterozygous for mb1-cre (CD45. 2+) and CD45.1+  
WT or heterozygous mb1-cre mice were mixed 1:1 and transferred into CD45.2+Rag-1/ mice (n = 4). After 8 wk, the recipient mice were immu-
nized with NP-CG. Splenocytes were stained with anti-CD45.1 mAb to distinguish the WT (45.1) and conditional Bcl6 KO (45.2) compartments at 
days 7 and 40 after immunization. The number of B cells and NP-specific memory and GC B cells in individual spleens was determined as in A. Data are 
representative of two (A) and three (B and C) independent experiments. See also Fig. S1.JEM Vol. 209, No. 11 
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in >98% of BM and splenic B cells, but not in prepro–B and 
CD4+ T cells (unpublished data). The conditional deletion 
of Bcl6 through mb1-cre essentially abolished the early devel-
opment of IgG1+ GC B cells in the spleen on day 5 after 
immunization (unpublished data). This in turn resulted in an 
200-fold reduction in the number of GC B cells on day 7 
after immunization, compared with the controls (Fig. 2 B). We 
also generated mixed BM chimeras by transferring BM cells 
of congenic CD45.1+ WT and CD45.2+ conditional Bcl6-
deficient mice into irradiated Rag-1/ mice and immunized 
the animals with NP-CG 8 wk after reconstitution. In the 
chimeric mice, Bcl6-deficient B cells did not generate GC   
B cells (Fig. 2 C), confirming that Bcl6 expression in B cells 
is essential for GC B cell development.
In contrast, the number of IgG1+ memory B cells was 
again comparable in Bcl6-deficient (Bcl6f/f/mb1-cre+/) and 
control mice (Bcl6+/+/mb1-cre+/) at days 7 and 40 after im-
munization (Fig. 2 B). In BM chimeric mice, memory B cells 
derived from WT and conditional Bcl6-deficient mice co-
existed at almost equal frequency in the spleen (Fig. 2 C), 
suggesting that GC-dependent and -independent pathways 
of memory cell generation operate side by side.
Figure 3.  The cell cycle position and VH186.2 gene mutations in NP-specific memory and GC B cells. (A) DNA content in memory (Me) and GC  
B cells in conditional Bcl6-deficient (Bcl6f/f/mb-1-cre+/) and control (Bcl6+/+/mb-1-cre+/) mice at days 7 and 40 after immunization with NP-CG. Each 
symbol represents the percentage of positive cells in an individual mouse (n = 3). Data are representative of three independent experiments. (B) The cell 
cycle position of memory B cells (Me) and GC B cells (GC) in FUCCI transgenic mice (n = 3) at indicated times. Each symbol represents the percentage of 
cells positive for Azami Green in an individual mouse. Data are representative of three (day 7) and two (day 40) independent experiments. (C and D) Single 
NP-specific/IgG1+ memory and GC B cells were purified from the pooled spleens of Bcl6+/+ (+/+) and Bcl6f/f (f/f) mice heterozygous for mb1-cre (n = 6–13) at 
day 7 (C) or day 40 (D) after immunization and subjected to RT-PCR to amplify rearranged VH186.2-C1 cDNA for sequencing (see Materials and meth-
ods). (E) CD45.1+ (45.1) WT memory and GC B cells and CD45.1 (45.2) Bcl6-deficient memory B cells were purified as single cells from pooled spleens  
of BM chimeras (n = 9) at day 40 after immunization and their VH genes were sequenced as in C. Number of mutated clones/number of V186.2 genes 
sequenced are also shown in C–E. Circles represent the number of mutations in individual clones. Closed circles represent W33L clones.2084 GC-independent memory B cell generation | Kaji et al.
Figure 4.  GC-independent memory B cells are maintained for a long period and later joined by somatically mutated GC descendents. (A) Bcl6+/+ (+/+), 
Bcl6+/f (+/f), and Bcl6f/f (f/f) mice heterozygous for mb1-cre (n = 5–25) were injected with BrdU twice at days 4–6 after immunization with NP-CG. Memory (Me) 
and GC B cells (GC) were then purified at indicated times. BrdU+ B cells were determined as in Materials and methods. Circles represent the percentage of BrdU+ 
cells in three independent experiments. (B) C57BL/6 mice (n = 5–25) were immunized and injected with BrdU as described in A. On days 6, 8, and 10 after immuniza-
tion, mice were either not treated () or injected with either hamster anti–CD40-ligand mAb (MR1) or normal hamster IgG (Ig) and sacrificed at day 20 or 40 for 
purification of NP-specific/IgG1+ memory (Me) and GC B cells (GC). BrdU incorporation was determined as in A. Circles represent the percentage of BrdU+ cells in 
three independent experiments. (C) Accumulation of mutations in VH186.2 genes that were PCR amplified from single NP-specific/IgG1+ memory B cells in immu-
nized WT mice (n = 10–22) at the indicated times. Number of mutated clones/number of V186.2 genes sequenced are also shown. Symbols are as in Fig. 3. The re-
sults were evaluated statistically by Mann-Whitney nonparametric test, with P < 0.05 regarded as significant. (D) C57BL/6 mice (n = 5) were immunized with NP-CG 
in alum and injected with or without () anti-CD40 ligand mAb (MR1) or normal Ig (Ig) as described in B. At day 20 or 40, the number of NP-specific/IgG1+ memory 
and GC B cells was analyzed by FACS. Each symbol represents the number of cells in individual mice. The data are representative of two independent experiments. 
(E) Immunofluorescence analysis of splenic cryosections from NP-CG–immunized C57BL/6 mice treated with MR1 or normal Ig was performed. Sections were 
stained with anti-B220 (blue) and PNA (red; see Materials and methods). Representative images of three mice are shown. Bars, 300 µm. (F) Mutational analysis of 
VH186.2 rearrangements from single day 40 memory B cells of immunized mice (n = 20–40). Mice were either not treated () or injected with anti-CD40 ligand 
mAb (MR1) or normal Ig (Ig) as described in B. Number of mutated clones/number of V186.2 genes sequenced are also shown. Symbols are as in Fig. 3.JEM Vol. 209, No. 11 
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Early GC-independent memory B cells are in a resting state 
and have not undergone SHM
To examine cell cycle progression in NP-specific/IgG1+ mem-
ory B cells, B cells were prepared from individual spleens of 
mutant (Bcl6f/f/mb1-cre+/) and control (Bcl6+/+/mb1-cre+/) 
mice at days 7 and 40 after immunization and stained with 
the DNA specific dye Hoechst 33342, followed by FACS 
analysis of their DNA content. Memory B cells in the mu-
tant mice were mostly in a resting state, whereas 20% of 
GC B cells in the controls are in the S/G2/M phases 
of the cell cycle at these time points (Fig. 3 A and 
Fig. S2 A). We also performed FACS analysis for 
NP-specific/IgG1+ memory and GC B cells in 
individual spleens of FUCCI transgenic mice at 
days 7 and 40 after immunization (Fig. 3 B). These 
mice constitutively express monomeric Azami Green 
fused to partial human geminin protein (Sakaue-
Sawano et al., 2008) so that cells in S/G2/M can be 
easily distinguished by green fluorescence (Fig. S2 B). 
Fig. 3 B shows that day 7 and day 40 IgG1+ mem-
ory B cells in WT mice were mostly in a resting 
state, in contrast to their GC counterparts. This was 
confirmed by staining for the Ki67 nuclear protein 
(unpublished data).
The anti-NP response in C57BL/6 mice is dominated by 
 light chain bearing antibodies whose V region of the IgH 
chain is encoded by a rearranged V186.2 V gene segment 
(Allen et al., 1988). As shown in Fig. 3 C, two thirds of the 
V186.2 rearrangements sequenced from IgG1+PNA+CD38+ 
and CD38dull GC B cells in Bcl6-proficient control mice were 
somatically mutated at day 7 after immunization, whereas IgG1+ 
memory B cells from mice with B cell–specific Bcl6 ablation 
(Bcl6f/f/mb1-cre+/) were unmutated. This was also true for 
Figure 5.  Memory B cells attain functional maturity as 
the immune response progresses. (A) Splenocytes were 
recovered from either naive or NP-CG–primed Bcl6+/+ (+/+), 
Bcl6+/f (+/f), and Bcl6f/f (f/f) mice (n = 4–14) heterozygous for 
mb1-cre (mb1-cre+/) at days 7 and 40 after immunization.  
B cells depleted of plasma cells were enriched by MACS and 
memory B cell frequency was estimated by FACS. B cell popu-
lations containing 1.5 × 103 NP-specific/IgG1+ memory B cells 
were transferred into Rag-1/ mice, together with CG-
primed CD4+ T cells and naive B cells, followed by immuniza-
tion with soluble NP-CG. The number of total and 
high-affinity anti-NP/IgG1+ ASCs in the spleen was measured 
by ELISPOT at day 10 after immunization. Shown are the total 
number of anti-NP/IgG1+ ASCs (left) and the ratio of high-
affinity ASCs/total number of ASCs (right). (B) On days 6, 8, 
and 10 after immunization, mice were either not treated () 
or injected with either anti-CD40 ligand mAb (MR1) or normal 
Ig (Ig) and sacrificed at day 7 (d7, n = 5) or 40 (d40, n = 22–25) 
for purification of NP-specific/IgG1+ memory B cells. Memory 
B cells (1 × 103), CG-primed CD4+ T cells (4 × 106), and naive 
B cells (106), as filler cells, were transferred into Rag-1/ 
mice (n = 4), followed by immunization as in A. Anti-NP/IgG1+ 
ASCs in the spleen were determined as in A. (C) B cells were 
prepared from mutant (Bcl6f/f/mb-1-cre+/, n = 4) or control 
mice (Bcl6+/+/mb-1-cre+/, n = 4) at day 70 (d70) after immu-
nization with NP-CG. NP-primed B cells or naive B cells  
(Naive) were transferred into Rag-1/ mice (n = 5), together 
with CG-primed T cells, followed by immunization with NP-
CG. The number of total and high-affinity anti-NP/IgM ASCs 
in the spleen was measured by ELISPOT at day 5 after immu-
nization. Data are representative of two (C) and three (A and B) 
independent experiments. Circles represent cell numbers in 
individual mice.2086 GC-independent memory B cell generation | Kaji et al.
Figure 6.  Gene expression profiles between days 7 and 40 memory B cells are closely related. (A) A hierarchical clustering of triplicate samples. 
Colors in the heat map depict the Pearson’s correlation coefficient between a pair of samples. A higher value is represented by dark blue as shown in the 
vertical bar. An AU (approximately unbiased) p-value (percentage) was calculated and placed on a branch of a cluster dendrogram. The values in red color 
indicate that the microarray pairs are significantly clustered. NP-specific/IgG1+ memory (Me) and GC B cells (GC) and plasma cells (Pc, day 7 only) were JEM Vol. 209, No. 11 
Article
2087
frequency of mutated cells in the memory B cell population 
from days 40 to 100 after immunization (Fig. 4 C). The fre-
quency of BrdU+ cells in the GC B cell population of the 
control mice significantly decreased from >95% on day 7 to 
<10% on day 40 (Fig. 4, A and B). This suggests that mutated 
GC progeny cells which have lost their BrdU label during 
proliferative expansion are gradually recruited into the mem-
ory compartment (Fig. 4 A).
To address this issue more directly, immunized WT mice 
were labeled with BrdU and then treated with the anti-CD40L 
mAb MR1 or control Ig at days 6 to 10 after immunization 
(Fig. 4 B). MR1 administration interfered with GC B cell 
development (Fig. 4, D and E; Takahashi et al., 1998) and the 
recruitment of mutated cells into the memory compart-
ment (Fig. 4 F). This was accompanied by a strongly diminished 
loss of BrdU-labeled cells from the memory compartment over 
time (Fig. 4 B). Together, these results indicate that GC-indepen-
dent memory B cells that develop within the first week of the 
response are maintained for a long period and joined by mu-
tated GC B cell progeny as the immune response progresses. 
In both conditional Bcl6-deficient and control mice, IgG1+ 
memory B cells localized within the follicles in the spleen at 
days 7 and 40 after immunization (unpublished data).
Early memory B cells gradually attain functional maturity
To determine the functional activity of memory B cells ap-
pearing early in the immune response, we tested their ability 
to generate an adoptive secondary response (Takahashi et al., 
2005). To this end, we purified IgM/IgD/B220+ B cells 
from the pooled spleens of mutant (Bcl6f/f/mb1-cre+/) and 
control (Bcl6+/+/mb1-cre+/ and Bcl6+/f/mb1-cre+/) mice 
at days 7 and 40 after immunization with NP-CG and deter-
mined the frequency of NP-specific/IgG1+ memory B cells 
in each population by FACS. An equivalent of 1,500 memory 
B cells was then transferred into Rag-1/ mice together 
with CG-primed T cells, followed by stimulation with soluble 
NP-CG. Fig. 5 A shows that both day 7 and day 40 memory 
cells from mutant as well as control mice induced an anti-
NP IgG1 secondary response, as determined by enumerating 
splenic antibody-secreting cells (ASCs). However, in all cases 
the response of the day 40 memory cells was more vigorous, 
with five to six times as many plasma cells generated. As 
expected, the antibodies produced by the mutant mice were 
mostly low affinity, in contrast to the mixture of high- and 
low-affinity antibodies produced by control mice. These re-
sults demonstrate that unmutated GC-independent memory 
day 7 memory B cells in Bcl6 proficient controls, except for a 
few cells carrying rearranged VH genes with a single mutation. 
The latter may represent early GC B cell progeny. At day 40 
after immunization (Fig. 3 D), all rearranged VH genes se-
quenced from GC B cells had accumulated a large number of 
mutations in control mice, and about half of the sequences 
from memory cells of these mice were mutated. The Trp to 
Leu exchange at aa position 33 of VH186.2 (W33L), which 
confers a 10-fold increase in affinity for the hapten NP (Allen 
et al., 1988), was detected in 15–45% of day 40 mutated 
memory and GC B cells (Fig. 3 D) and further enriched in 
mutated VH186.2 genes joined to DFL16.1 in day 40 memory   
B cells (27–64%; not depicted), comparable to the observa-
tions by Weiss and Rajewsky (1990). In contrast, day 40 mem-
ory B cells in Bcl6-deficient mice were still free of somatic 
mutations (Fig. 3 D). Similarly, in mixed BM chimeric mice 
(Fig. 2 C), Bcl6-deficient memory B cells did not accumulate 
mutations (Fig. 3 E), confirming that even in the presence of 
GC reactions Bcl6 deficiency precludes the acquisition of 
SHMs by B cells.
GC-independent memory B cells arise from dividing 
precursors, are long-lived, and enter the memory 
compartment before GC B cell progeny
To determine the lifespan of unmutated memory B cells, we 
administered BrdU intraperitoneally into mutant (Bcl6f/f/
mb1-cre+/) and control (Bcl6+/+/mb1-cre+/) mice on days 
4 and 6 after immunization, to mark splenic B cells deriving 
from precursors dividing during the labeling period. We then 
isolated NP-specific/IgG1+ memory B cells 7 and 40 d after 
immunization and analyzed the frequency of BrdU-labeled 
cells by confocal microscopy (Fig. 4 A; Takahashi et al., 2001; 
Toyama et al., 2002). More than 95% of day 7 memory B cells 
from both mutant and control mice had incorporated BrdU, 
and this frequency declined only slightly in the mutant mice 
by day 40 after immunization. As IgG1+ memory B cells are 
in a resting state from day 7 on (Fig. 3), this suggests that most 
GC-independent memory B cells have a long lifespan. In con-
trast, in the control mice, the frequency of BrdU-labeled mem-
ory B cells was reduced at day 40 to 60% (P = 0.005).
In immunized WT mice, BrdU-labeled memory B cells 
decreased from >95% on day 7 to 70% on day 20 (P = 
0.023) and 60% on day 40 (P ≤ 0.005) after immunization 
(Fig. 4 B), in parallel with an increase in the frequency of mu-
tated cells from ≤5% at day 7 to 30% at day 20, and 50–66% 
at day 40 (Fig. 4 C). There was no significant increase in the 
purified from WT mice at day 7 (n = 14–20) and day 40 (n = 30–39) after immunization for extraction of total RNA. FO and MZ B cells were purified from 
unimmunized mice (n = 3). FO B cells were stimulated with anti-IgM and anti-CD40 mAb in vitro for 6 h (FO + stimulation). (B) qRT-PCR analysis for can-
didate genes identified in the microarray data analysis. NP-specific/IgG1+ memory (Me) and GC B cells and plasma cells (Pc) were purified from WT mice 
(n = 10) at day 7 after immunization. Day 40 memory B cells were purified from the pooled spleens of immunized mice (n = 18–25), treated with anti-
CD40L mAb (MR1), control Igs, or left untreated. cDNA synthesized from total RNA was used for qRT-PCR with the indicated gene-specific primers (see 
Table S1) and standardized to the relative expression of -actin. Shown here are gene expression profiles of naive FO (a) and MZ B cells (b), and memory 
(c), GC (d), and plasma cells (e) at day 7 after immunization. Also shown are day 40 memory B cells that developed in untreated mice (f) or those treated 
with either control Igs (h) or MR1 (j), together with day 40 GC B cells in untreated mice (g) or those treated with Igs (i). FO B cells stimulated as in A for  
6 h (k) and 24 h (l) are also shown. Data are representative of two independent experiments. Error bars represent ±SD. See also Fig. S3.
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Figure 7.  Different subsets of T cells support GC-independent and -dependent memory B cell development. (A) CD40 KO (/) and control 
(+/+) mice were immunized with NP-CG and generation of NP-specific/IgG1+ B cells was analyzed by FACS (left). Circles represent the number of cells in 
individual mice (n = 3, right). (B–D) Frequencies of Tfh (B), NP-specific/IgG1+ GC (C), and memory B cells (D) in spleens of Bcl6+/+ (+/+) and Bcl6f/f (f/f) 
mice carrying a CD4-cre transgene at days 7 and day 40 after immunization with NP-CG. Unimmunized mice were used as a control in B. Circles repre-
sent the number of cells in individual mice (n = 4–6). (E) The frequency of day 7 NP-specific/IgG1+ memory and GC B cells in the spleens of mutant  
(Bcl6f/f/mb1-cre+/ and CD4-cre) and control (Bcl6+/+/mb1-cre+/ and CD4-cre) mice. Circles represent the number of cells in individual mice (n = 4).  JEM Vol. 209, No. 11 
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and -dependent memory cells share at least part of their gene 
expression signature. In addition, the level of transcripts was 
comparable between day 7 memory B cells in both the con-
ditional Bcl6-deficient and control mice (unpublished data).
The differentially expressed transcripts fall into three groups: 
transcription factors, which include the AP-1 family of JunB 
and Fra-2 (van Dam and Castellazzi, 2001) and the NR4A 
subfamily of nuclear orphan receptors (Maxwell and Muscat, 
2006), receptors, such as Tnfrsf1b encoding for TNFR2, and 
signaling intermediates, including the suppressor of cytokine 
signaling (SOCS) family, Socs3 (Alexander and Hilton, 2004).
Day 7 and 40 GC-independent memory B cells shared a 
group of transcripts, including NR4a2, Fra-2, and Socs3, sug-
gesting that these cells sustained the expression of a group of 
transcripts over time from day 7 onward. The level of certain 
other transcripts increased or decreased in GC-independent 
memory B cells over time (Fig. 6 B). An example of this is 
leukemia inhibitory factor receptor (Lifr), which is preferen-
tially expressed in early memory B cells. In contrast, expres-
sion of NR4a1 and NR4a3 was higher in cells harvested at 
day 40. These results suggest gene expression changes in GC-
independent memory cells over time, perhaps in response to 
environmental cues.
GC-independent and -dependent memory B cells develop 
with the help of different T cell subsets
IgG1+ memory and GC B cells were generated neither in 
CD40-deficient mice (in which T cell help cannot be delivered 
to B cells; Kawabe et al., 1994 and Fig. 7 A) upon NP-CG 
immunization nor in WT mice immunized with NP-Ficoll, a 
T cell–independent antigen (not depicted). These results in-
dicate that the development of IgG1+ memory B cells re-
quires T cell help. To address the role of Tfh cells in memory 
B cell development, we crossed the Bcl6f/f mice with mice 
carrying a cre transgene under the control of the cd4 enhancer/
promoter (CD4-cre). The conditional deletion of Bcl6 through 
CD4-cre did not affect T and B cell numbers and their phe-
notype in naive animals (not depicted) but impaired Tfh de-
velopment in mice immunized with NP-CG (Fig. 7 B). Mutant 
mice had significantly reduced numbers of splenic NP-specific/
IgG1+ GC B cells (Fig. 7 C) at day 7 after immunization, but the 
frequency of mutations in VH gene rearrangements was com-
parable in mutant and control mice (Fig. 7 F).
The number of IgG1+ memory B cells was comparable at 
day 7 after immunization in control and mutant mice with 
conditional deletion of Bcl6 in T cells (Fig. 7 D) and in both 
B and T cells (Fig. 7 E), indicating that a Tfh subset of T cells 
is not required for the generation of GC-independent mem-
ory B cells. However, at day 40 after immunization, memory 
B cells have the capacity to generate a low-affinity secondary 
response and, like GC-derived memory cells, attain functional 
maturation as the immune response progresses.
To confirm that this maturation process also takes place 
in WT mice, we administered the MR1 mAb or control Ig 
into immunized WT mice, as described in Fig. 4 B. We then 
purified day 7 and 40 NP-specific/IgG1+ memory B cells 
from the two groups of mice and transferred 1,000 such cells 
together with CG-primed T cells into Rag-1/ mice to 
analyze their secondary response. Fig. 5 B shows that day 7 
memory B cells respond to boosting antigen, consistent with 
the results in Fig. 5 A. Significantly, day 40 memory B cells 
from MR1-treated mice produced larger numbers of ASCs, 
comparable to those produced by control day 40 memory   
B cells. However, in contrast to the latter they expressed ex-
clusively low-affinity antibodies.
There is evidence that not only class-switched but also 
IgM+ memory B cells are generated in both T cell–dependent 
and –independent responses (Klein et al., 1997; Weller et al., 
2001; Obukhanych and Nussenzweig, 2006; Anderson et al., 
2007; Dogan et al., 2009: Pape et al., 2011; Taylor et al., 2012). 
Fig. 5 C shows that NP-primed B cells of conditional Bcl6-
deficient and control mice generated a modest IgM adop-
tive secondary response consisting mostly of low-affinity 
antibodies. This raises the possibility that IgM+ memory   
B cells can be generated through a GC-independent pathway 
(see Discussion).
Early and late memory B cells have closely related gene 
expression profiles
Gene  expression  was  assessed  using Affymetrix  GeneChip 
technology in three replicates of day 7 and 40 NP-specific/
IgG1+ memory B cells, GC B cells, and plasma cells in im-
munized mice and naive marginal zone (MZ) and FO B cells, 
before and after activation in vitro. Hierarchical cluster analy-
sis for all arrays on the expression of 45037 probes displayed a 
dendrogram with five major branches (Fig. 6 A). Early and 
late memory B cells were included in the same group, next to 
naive B cells and clearly separated from other B cell types.
To identify genes selectively up-regulated in the memory 
cells, we quantified gene expression by statistical analyses and 
detected 94 candidate genes (Fig. S3). Assessing the expression 
of these genes by quantitative RT-PCR (qRT-PCR) in mem-
ory B cells of MR1-treated or control animals, we identified 
24 genes whose increased expression in either or both day 7 
and 40 memory B cells was reproduced in two independent 
biological replicas (Fig. 6 B). The levels of these transcripts 
were comparable between day 40 memory B cells from MR1-
treated and control animals, suggesting that GC-independent 
(F and G) Mutational analysis of VH186.2 rearrangements from NP-specific/IgG1+ memory and GC B cells of Bcl6+/+ (+/+) and Bcl6f/f (f/f) mice carrying a 
CD4-cre transgene at days 7 (F) and 40 (G) after immunization (n = 4–6). Circles represent the number of mutations in individual clones. Number of mutated 
clones/number of V186.2 genes sequenced are also shown in F and G. Closed circles represent high-affinity clones (W33L). (H) NP-specific/IgG1+ memory 
B cells were purified from Bcl6+/+ (+/+) and Bcl6f/f (f/f) mice carrying a CD4-cre transgene (n = 10–19) at day 40 after immunization and their secondary 
response was assessed as in Fig. 5. Response by naive B cells was also assessed as a control. Circles represent the number of anti-NP/IgG1+ ASCs in the 
spleens of individual mice at day 10 after immunization (n = 4). The data are representative of two independent experiments in A–E and H.
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Figure 8.  Expression of PD-L2 and CD80 on GC-independent and -dependent memory B cells. (A) Histograms represent the relative intensity of 
indicated surface markers on naive B cells (darkly shaded), day 7 and day 40 memory B cells (solid line), and GC B cells (dashed line) in mutant (Bcl6f/f/ 
mb-1-cre) and control (Bcl6+/+/mb-1-cre) mice. Representative results of two independent experiments with three mice per group are shown. (B) Accumula-
tion of mutations in VH186.2 genes that were PCR amplified from single CD73+ and CD73 NP-specific/IgG1+ memory B cells and GC B cells in immunized 
WT mice (n = 5) at day 40 after immunization. Number of mutated clones/number of V186.2 genes sequenced are also shown. Symbols are as in Fig. 3.
B cell numbers were reduced in the mutant mice by 40% 
(Fig. 7 D) as a result of a significant reduction in the number 
of mutated cells in the memory B cell population (Fig. 7 G). 
Consistent with these data, day 40 memory cells from both 
mutant and control mice initiated an IgG1 secondary response, 
but the antibodies produced by the mutant cells were mostly 
of low affinity, in contrast to the mixture of high- and low-
affinity antibodies produced by the controls (Fig. 7 H). The 
results suggest that Tfh depletion impaired the development 
of mutated memory cells, owing to a failure in expansion 
and/or maintenance of GC B cells.
Cell surface markers on GC-independent and -dependent 
memory B cells
PD-L1, PD-L2, CD80, CD73, and CD35 have all been re-
ported to be expressed in memory B cells in the spleen   
(Anderson et al., 2007; Good-Jacobson et al., 2010). Fig. 8 A 
shows that the level of PD-L2 and CD80 was increased in day 
7 and 40 memory B cells in conditional Bcl6-deficient and 
control mice compared with naive and GC B cells. Interest-
ingly, both GC-independent and -dependent memory B cells 
increased their levels of PD-L2 on the surface from day 7 to 
day 40 after immunization. CD73 expression was increased 
in GC and a subset of memory B cells in WT mice as the 
immune response progresses. Fig. 8 B shows that 80% of 
CD73+ memory B cells accumulated somatic mutations com-
pared with 30% of CD73 memory cells. Thus, mutated 
memory B cells are enriched in the CD73+ subset, as sug-
gested by Taylor et al. (2012).
Cell population dynamics in memory B cell development
To study the generation of GC-independent memory B cells 
from naive B cell precursors, we used mice (CD45.1+) in 
which the frequency of NP-specific naive B cells is enhanced 
(B1-8hi; Shih et al., 2002). Splenic B cells of these mice were 
transferred into syngeneic CD45.2+ recipients and immu-
nized with NP-CG. This causes the synchronous activation of 
many NP-specific donor B cells, allowing us to dissect their 
early response in vivo. Fig. 9 (A and B) shows that a small frac-
tion of NP-binding donor B cells acquired sIgG1 expression 
and increased in number from day 3 to 4 after immunization, 
a period in which PNA binding cells were barely detectable. 
The IgG1+ donor B cells expressed memory surface markers, 
but not intracellular Bcl6 (Fig. 9 C), and increased expression 
level of genes, which were detected in day 7 memory B cells in 
the adoptive recipients and intact immunized mice (Fig. 9 D). 
Administration of MR1 mAb into the recipients from days 
3–6 after immunization blocked Bcl6 expression and reduced 
the expansion of NP-specific/IgG1+ B cells (Fig. 9, B and C). 
However, these cells still acquired expression of memory 
surface markers and genes which we had detected in day 7 
memory B cells developing in the absence of MR1 treatment 
(Fig. 9, C and D). The levels of these transcripts were compa-
rable between memory cells from MR1-treated and control 
animals (Fig. 9 D). The IgG1+ B cells did not detectably ex-
press the GC B cell–specific gene M17 (Christoph et al., 
1994) or Blimp-1 associated with plasma cell differentiation 
(Angelin-Duclos et al., 2000). Together, these data suggest that 
antigen-activated IgG+ B cells can differentiate toward mem-
ory B cells through initial proliferative expansion, in the ab-
sence of Bcl6 expression.
DISCUSSION
Memory B cells are long-lived quiescent B cells capable of 
eliciting more rapid and robust antibody responses upon anti-
genic stimulation than antigen-inexperienced naive B cells JEM Vol. 209, No. 11 
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1997; Ye et al., 1997), 
and deleted it spe-
cifically in B cells. 
We also interfered with GC formation using an antagonistic 
Ab against CD40L, whose interaction with the CD40 co-
receptor on B cells is critical for the GC reaction (Kawabe 
et al., 1994). In contrast to deletion in the germ line, condi-
tional Bcl6 deletion in the B cell lineage affected neither   
B cell development and subset distribution in terms of num-
bers nor the initial expansion of antigen-activated B cells after 
immunization; however, it precluded the development of 
GC B cells from day 5 after immunization, the earliest time 
point at which such cells became apparent in WT mice.
Under these conditions, IgG1+ memory B cells developed 
within 7 d after immunization like in WT mice, apparently inde-
pendently of the GC reaction. BrdU incorporation experiments 
(Tangye and Tarlinton 2009). Based on this generally accepted 
definition, we pursued the fate of NP-specific/IgG1-express-
ing memory cells in the T cell–dependent response and 
characterized their development, properties, genetic signa-
ture, and functional activity. As GC reactions persisted over 
5 mo after priming after immunization with NP-CG, we 
used FACS with multicolor parameters throughout to distin-
guish memory cells from GC B cells (Takahashi et al., 2001; 
Blink et al., 2005).
A GC-independent pathway of memory B cell genera-
tion had been predicted or inferred in previous studies (Weller 
et al., 2001; Toyama et al., 2002; Blink et al., 2005; Inamine 
et al., 2005; Chan et al., 2009; Zotos et al., 2010: Taylor et al., 
2012). To obtain definitive evidence for this differentiation 
pathway, we generated a conditional allele of Bcl6, a tran-
scriptional repressor essential for GC formation (Dent et al., 
Figure 9.  Antigen-engaged IgG1+ B cells 
differentiate into memory cells prior to 
the appearance of Bcl6 expressing pre-GC 
B cells. (A) C57BL/6 (CD45.2) mice (n = 3–4) 
were injected with B220+ B cells from B1-8hi 
mice (CD45.1) and immunized with NP-CG, 
followed by FACS analysis. NP-specific/B220+ 
B cells of donor origin (CD45.1+) in the immu-
nized or unimmunized recipients were gated 
and their PNA binding and IgG1 expression 
were analyzed (left). (B) Numbers of NP-spe-
cific/IgG1+/PNA () and PNA+ (+) B cells 
from day 3–4 (left) and NP-specific/IgG1+ 
memory B cells (CD38+/PNA, Me) and GC  
B cells (CD38dull/PNA+, GC) at day 7 (right) after 
immunization. MR1 was administered from 
days 3 to 6 after immunization as in Fig. 4 B. 
(C) Expression of surface PD-L2 and CD80 and 
intracellular Bcl6 analyzed by FACS in NP-
binding B cells from unimmunized recipients 
(control B cells) and NP-specific/IgG1+ B cells 
and GC and memory B cells in recipients at 
different time points after immunization. 
Memory B cells were purified from recipients 
treated or not treated with MR1. Representa-
tive results of three independent experiments 
are shown in A–C. (D) Gene expression pro-
files in NP-specific/IgG1+ donor B cells at day 
3 (b) and day 4 (c) after immunization and 
day 7 NP-specific/IgG1+ memory B cells in 
MR1-treated (e) or -untreated (d) recipients, 
together with GC B cells in untreated recipi-
ents (f). NP-binding B cells from unimmu-
nized recipients served as controls (a). Total 
RNA was purified from B cells and cDNAs 
were synthesized for qRT-PCR with the indi-
cated gene-specific primers. Also shown are 
gene expression profiles of naive FO B cells 
(g), MZ B cells (h), day 7 and day 40 memory 
B cells (i and l), GC B cells (j and m), plasma 
cells (k), and activated FO B cells (compare 
Figure 6; FO + Stim). Error bars represent ±SD. 
Data are representative of two independent 
experiments and standardized to the expres-
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expressed by 80% mutated and 30% unmutated memory 
cells), the genetic heterogeneity of the mixed BM chimeras 
used by Taylor et al. (2012), and the possibility that Freund’s 
complete adjuvant–induced Th1-dominated helper activity 
(Billiau and Matthys, 2001; McKee et al., 2007; Taylor et al., 
2012) and alum-induced Th2-dominated helper activity differ-
entially drive and sustain GC-independent B cell memory.
Another issue raised by Taylor et al. (2012) relates to IgM 
expressing memory cells. Although the prominent isotypes 
expressed in secondary antibody responses require CSR, there 
is evidence that a subset of memory cells retains IgM expres-
sion and may even play a specific role in an antigen-dependent 
pathway of memory propagation (Anderson et al., 2007; 
Dogan et al., 2009). IgM-expressing memory B cells may 
also be generated in T cell–independent antibody responses 
(Obukhanych and Nussenzweig, 2006). Taylor et al. (2012) 
report that upon immunization, CD38+/GL7/IgM+ B cells 
expand in a GC-independent manner, 100-fold above the 
level of GC-independent isotype-switched Ig+ memory cells. 
Our results suggest that these former cells do not contribute 
significantly to the memory response, given the low magni-
tude of their adoptive secondary response.
Although the global gene expression analysis performed 
on GC-dependent and -independent IgG1+ memory cells 
remains descriptive at this stage, it has provided interesting   
insights into the development and relatedness of these cells. 
Thus, we identified a distinct gene expression signature dis-
tinguishing both types of memory B from other classes of 
B cells already at day 7 after immunization. This signature 
was shared by GC-dependent and -independent memory cells 
and included several transcription factors specifically up-
regulated in these cells. Interestingly, most of the genes up-
regulated in either or both day 7 and 40 memory B cells 
discovered in the present experiments were not detected in 
earlier studies addressing memory B cell–specific gene expres-
sion (Bhattacharya et al., 2007; Tomayko et al., 2008), with the 
exception of Lifr and adenosine receptor A2a (Adora2a; 
Tomayko et al., 2008) and Nidogen1 (Bhattacharya et al., 2007). 
These discrepancies may be a result of the fact that in the 
earlier studies GC B and plasma cells were not depleted from 
the memory B cell preparations. Alternatively, they may re-
flect differences between memory B cells expressing different 
Ig isotypes.
Although the functional significance of the memory B 
cell specific genes and also of changes of gene expression in 
these cells over time remain to be determined, it is interesting   
to speculate about a possible connection between the func-
tional maturation of memory cells over time and the up-
regulation of certain surface markers known to be involved 
in their interaction with T helper and DCs, such as PD-L2, 
CD80, and CD73 and expressed on subsets of memory B cells 
(Anderson et al., 2007; Good-Jacobson et al., 2010). We con-
firmed that PD-L2, CD80, and also costimulatory molecules 
like MHC class II and CD40 are expressed on both GC- 
independent and -dependent memory B cells, with an interest-
ing increase of PD-L2 expression from day 7 to day 40 after 
demonstrated that after initial proliferative expansion these 
cells acquire a resting state already at day 7 after immunization 
and persist for long periods of time. In immunized WT mice, 
the memory pool initially contains a very large proportion 
of nonmutated cells. However, the frequency of nonmutated 
memory B cells gradually decreases to approximately one 
half as the immune response progresses. Blocking cell influx 
from GCs prevented the recruitment of mutated cells into the 
memory compartment, indicating that these cells represent 
GC progeny, which access the memory compartment as the 
GC reaction unfolds. Consistent with this model, blockade 
of CD40-CD40L interaction by anti-CD40L mAb at days 
20–24 after immunization results in the dissolution of estab-
lished GCs, whereas the number of day 40 memory B cells is 
largely unaffected (Takahashi et al., 2001). Collectively, these 
results suggest that nonmutated GC-independent memory 
B cells develop early in the response of both WT and condi-
tional Bcl6-deficient mice and are maintained for long peri-
ods of time.
Dissecting the early T cell–dependent B cell response   
in vivo through an adoptive transfer system with largely syn-
chronous activation of NP-specific donor B cells (Shih et al., 
2002), we obtained evidence that antigen-engaged IgG1+ 
B cells can differentiate into memory cells before the appear-
ance of Bcl6 expressing pre-GC B cells. Bcl6 up-regulation in 
the latter cells is thought to promote their interactions with 
Tfh cells, which are required for GC formation (Crotty 2011; 
Kitano et al., 2011). In accord with this notion, we observed 
that the loss of Tfh cells through T cell–specific deletion of 
Bcl6 significantly reduced the generation of mutated memory 
B cells in T cell–dependent responses as a consequence of 
impaired GC development. In contrast, the generation of 
GC-independent memory cells followed its normal path in 
the absence of Tfh cells and is therefore driven by a separate 
T helper cell subset. Thus, different T cell signals, perhaps 
through differential engagement of CD40 (Taylor et al., 2012), 
may drive naive B cells into distinct pathways of memory 
cell generation.
While  the  present  paper  was  in  revision, Taylor  et  al. 
(2012) reported that antigen-specific B cells with a memory 
phenotype (CD38+/GL7) are generated in GC-independent 
and -dependent manners in WT and Bcl6/ BM chimeric 
or anti-CD40L–treated mice in response to PE. Although the 
functional properties of these cells were not analyzed, it was 
satisfying to see cells of similar phenotypes as observed in our 
study arising in response to yet another T cell–dependent 
antigen.  However,  there  were  important  discrepancies  be-
tween the present study and Taylor et al. (2012) with respect 
to the persistence of GC-independent memory cells. Taylor   
et al. (2012) found these cells at a strong disadvantage in compe-
tition with GC progeny in mixed BM chimeras. In contrast, our 
results not only suggest peaceful coexistence of the two pop-
ulations but also their functional maturation over time, an   
issue not addressed in Taylor et al. (2012). Among possible 
reasons for this discrepancy are the use of CD73 as a marker 
for GC-derived memory B cells (a marker which we find JEM Vol. 209, No. 11 
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immunization. As expression of PD-L2 is required for optimal 
ASC generation (Good-Jacobson et al., 2010), the functional 
activity of memory B cells could be related to the level of 
PD-L2 expression.
As a general perspective, our results reveal that the im-
mune system has evolved distinct differentiation pathways to 
select two classes of antibody binding sites into the memory 
compartment, namely those that have been subject to evolu-
tionary selection and others selected for high-affinity antigen 
binding in the GC reaction, through rapid somatic evolution. 
In the context of immune defense against infection, it seems 
reasonable to assume that the germ line–encoded antibody 
repertoire is constantly evolving to provide cross-reacting 
specificities that are particularly useful as a first line of defense 
against common pathogens and whose exclusion from the 
memory compartment would be wasteful. The generation of 
high-affinity somatic mutants, in contrast, allows the system 
to focus on a particular pathogen at the expense of loosing 
useful cross-reactivities. We speculate that responses to vari-
ants of invading pathogens may involve the rapid recruitment 
of cells from the pool of unmutated memory cells into GC 
reactions. In this picture, the memory compartment consists 
of two layers of cells, those optimally adapted to the invading 
pathogen and others providing the substrate for the selection 
of somatic mutants adapted to antigenic variants arising in   
the course of infection. It is possible that this second layer of 
memory cells also contains non–class-switched IgM+ cells, 
which we have been unable to analyze because of the lack of 
suitable surface markers. Finally, it is tempting to speculate, 
that the two classes of human B cell chronic leukemia, which 
are distinguished by the presence or absence of somatic muta-
tions in their antibody V region genes and whose clinical 
prognosis differs dramatically (Hamblin et al., 1999), may de-
rive from the two classes of memory cells described here.
MATERIALS AND METHODS
Mice and immunizations. 8–10-wk-old C57BL/6 female mice were pur-
chased from Clea Inc. Mb1-cre mice were provided by Dr. M. Reth (Uni-
versity of Freiburg and Max-Planck Institute for Immunobiology, Freiburg, 
Germany). Fucci-expressing transgenic mice were provided by Dr. Miyawaki 
(RIKEN Brain Science Institute, Saitama, Japan). C1-cre mice have been 
described previously. FLPe-expressing deleter mice were provided by the 
RIKEN BRC through the National Bio-Resource Project of the MEXT, 
Japan. Rag-1/ and CD4-cre mice were obtained from Taconic. Mice were 
immunized intraperitoneally with 100 µg NP15-CG precipitated in alum 
(Takahashi et al., 2001) or, in some experiments, with 50 µg NP-Ficoll (Bio-
search Technologies) in PBS. All experiments were performed in accordance 
with guidelines established by the RIKEN Animal Safety Committee.
Generation of Bcl6 conditional knockout mice. Bcl6f mice were gen-
erated by targeted insertion of loxP sites to flank exon 7–9 of the Bcl6 gene 
(Fig. 1). To construct the targeting vector, we subcloned the genomic DNA 
fragment encoding exons 5–10 of Bcl6 gene from the C57BL/6 embryonic 
stem (ES) cell line Bruce4 (Köntgen et al., 1993) by PCR. A loxP site was   
inserted between exons 6 and 7, and the Gateway rfA cassette (Invitrogen) 
between exons 9 and 10. The diphtheria toxin A selection cassette from 
pEZ-Frt-lox-DT was joined at the 3 adjacent position of exon 10. The in-
serted Gateway rfA cassette was then replaced with a fragment containing 
loxP site and combined with an FRT-flanked neo-resistance cassette by a 
recombination reaction using LR clonase (Invitrogen). The targeting con-
struct was transfected into Bruce4 ES cells by electroporation. G418-resistant 
colonies were expanded, and the appropriately targeted clones were screened 
by PCR and Southern blot analysis. Established ES clones were injected into 
blastocysts from BALB/c mice to produce chimeric mice. The pGK-Neo 
cassette was removed from the mouse germline by breeding heterozygous 
mice to FLPe-expressing deleter mice (Kanki et al., 2006). Bcl6f/+ mice were 
crossed to mb1-cre mice, C1-cre mice, or CD4-cre mice to obtain condi-
tional knockout strains.
Flow cytometric analysis for memory and GC B cells. This was per-
formed as previously described (Takahashi et al., 2001, 2005). In brief,   
to prepare single cell suspension, spleens were minced and incubated with 
200 U/ml collagenase IV (Sigma-Aldrich) and 20 µg/ml DNase I (Roche) 
for 30 min at 37°C. After washing, splenocytes were depleted of red blood 
cells and incubated with anti-FcRII/III mAb (2.4G2; American Type Cul-
ture Collection). For memory and GC B cell analysis, cells were incubated 
with a mixture of biotinylated mAbs against IgM, IgD, CD3, CD5, CD90, 
TER119, Gr-1, F4/80, DX5, AA4.1, and NK1.1 (eBioscience), followed 
by staining with anti-CD38 (CS2; Inamine et al., 2005) conjugated with 
Alexa Fluor 647 (CD38AlexaFluor647), anti-B220 conjugated with PE-Cy7 (anti-
B220PE-Cy7; eBioscience), anti-IgG1 conjugated with Pacific Blue (anti-IgG-
1PacificBlue; BD), PNA conjugated with FITC (PNAFITC; Vector Laboratories), 
(4-hydroxy-5-iodo-3-nitrophenyl)acetyl (NIP)-BSA conjugated with PE 
(NIP-BSAPE), and streptavidin conjugated with PE–Texas Red (streptav-
idinPE-TexasRed; BD). In C57BL/6 mice (IgHb haplotype), -bearing B cells 
responsive to NP generally produce antibodies that have higher affinities 
for analogues of NIP than for NP itself (heteroclicity; Reth et al., 1979). 
Therefore, we used NIP-BSAPE, instead of NP-BSA, for detection of NP-
specific B cells in the spleen of immunized and nonimmunized mice. Cells 
were washed, resuspended in a staining buffer containing 1 µg/ml propidium 
iodide, and analyzed using a FACSAria (BD). To improve the accuracy of 
lymphocyte subset analysis, only cells exhibiting forward and large-angle 
scatter typical of lymphocytes (the lymphocyte gate; eliminating monocytes 
and granulocytes) were analyzed (Hayakawa et al., 1987; Takahashi et al., 
2001). For all experiments reported here, only cells negative for streptav-
idinPE-TexasRed and PI staining were gated for further analysis. More than one 
million total events were collected for each file in and then analyzed using 
FlowJo software (Tree Star).
Analysis of memory and GC B cells of BM chimeric mice. Spleno-
cytes from NP-CG immunized mice were incubated with a mixture of bio-
tinylated mAbs, as described in the previous section, followed by staining 
with anti-CD45.1APC (eBioscience), anti-IgG1PacificBlue, anti-B220 conju-
gated with efluor605 (anti-B220efluor605; eBioscience) or anti-B220 conjugated 
with V500 (anti-B220V500; BD), anti-CD38 conjugated with PE-Cy7 (anti-
CD38PE-Cy7; BioLegend), NIP-BSAPE, PNAFITC, and streptavidinPE-TexasRed at 
day 7 after immunization. For analysis of day 40 memory and GC B cells, 
cells were stained with anti-CD45.1APC, anti-IgG1PacificBlue, anti-CD38PE-Cy7, 
NIP-BSAPE, anti-B220FITC, and streptavidinPE-TexasRed. In single cell sorting 
for VH sequence analysis, IgIgMIgD B cells were selected using a MACS 
system (Miltenyi Biotec) as described in Takahashi et al., (2001), followed by 
staining with fluorescent reagents, including anti-CD45.1APC.
Analysis of surface antigens on memory B cells. Splenocytes were in-
cubated with a mixture of biotinylated mAbs as described in flow cytometric 
analysis, followed by staining with anti-B220V500, anti-CD38PE-Cy7, NIPAPC, 
NIP-BSAPE, PNAFITC, or anti-IgG1PacificBlue for immunized mice or anti-
IgMPacificBlue for unimmunized mice and streptavidinPE-TexasRed. In addition 
anti-PD-L2PE, anti-CD73PE, anti-CD80PE, anti-CD35AlexaFluor647, anti-CD40APC, 
or anti–MHC class IIAPC mAbs were stained.
Analysis of BM B cells. BM B cells were prepared from Bcl6+/+, Bcl6+/f, 
and Bcl6f/f mice heterozygous for mb1-cre. BM cells were incubated with 
biotinylated mAbs against CD3, CD5, CD90, TER119, Gr-1, CD11b, DX5, 2094 GC-independent memory B cell generation | Kaji et al.
mice, we used Fucci transgenic mice, which constitutively express mono-
meric Azami Green fused to partial human geminin protein (Sakaue-Sawano 
et al., 2008). Splenocytes from NP-CG immunized Fucci transgenic mice 
were incubated with a mixture of biotinylated mAbs and streptavidin micro-
beads. Thereafter, the cells negatively selected by the MACS system (Milte-
nyi Biotec) were stained with anti-B220efluor605, PNA conjugated with Alexa 
Fluor 647 (PNAAlexaFluor647; Invitrogen), anti-CD38PE-Cy7, anti-IgG1PacificBlue, 
NIP-BSAPE, and streptavidinPE-TexasRed for FACS analysis.
Analysis for early memory B cell development. To study the genera-
tion of GC-independent memory B cells from naive B cell precursors, we 
used mice in which the frequency of NP-specific naive B cells is enhanced 
through the knockin of a rearranged, mutant  V186.2 gene segment encoding 
high-affinity binding for the hapten NP into the IgH locus (B1-8hi; Shih 
et al., 2002). Splenic B cells of these mice, which bear the CD45.1 genetic 
marker on their lymphocytes were transferred into syngeneic CD45.2   
recipients and immunized with NP-CG. This causes synchronous activation of 
many NP-specific donor B cells, allowing us to dissect their early response 
in vivo. 3, 4, and 7 d after immunization, Ig B cells in the immunized recipi-
ents were analyzed or enriched by MACS and subjected to FACS and qPCR 
analyses. For staining intracellular Bcl6, MACS-enriched cells were first stained 
with Fixable Viability Dye eFluor780 (eBioscience), followed by staining for 
surface antigens. Cells were then fixed, permeabilized using the Foxp3 stain-
ing buffer set (eBioscience), and stained with anti-Bcl6PE mAb (BD).
Immunohistofluorescence assay. Immunohistofluorescence assay was per-
formed as described previously (Inamine et al., 2005).
B cell stimulation. Splenic B cells from individual mice (n = 3) were puri-
fied using a MACS system and stimulated in triplicate with 10 µg/ml anti–
mouse IgM F(ab’)2 (Jackson ImmunoResearch Laboratories) and 2 µg/ml rat 
anti–mouse CD40 mAb (eBioscience) or 20 µg/ml LPS (Sigma-Aldrich) for 
3 d. The cytokines levels in the culture supernatants were determined by 
Bio-Plex cytokine multiplex assay (Bio-Rad Laboratories) according to the 
manufacturer’s instructions.
DNA microarray analysis. The DNA microarray analysis for memory 
B cells from wild-type mice was performed with Affymetrix GeneChip Mouse 
430 2.0 Arrays. The total RNAs were extracted using TRIzol reagent (Invit-
rogen). RNA samples were labeled using an Ovation RNA Amplification 
System  V2 and FL-Ovation cDNA Biotin Module  V2 kits (Nugen) for mem-
ory B cell analysis (Fig. 6). Image files were scanned and processed by GCOS 
(GeneChip Operating Software) and the microarray data were normalized 
with GCRMA. A cluster analysis was performed using pvclust (Suzuki and 
Shimodaira, 2006) as follows: Pearson’s correlation coefficients in each pair   
of the gene expression profiles were calculated to make a dendrogram for 
the samples. The AU (approximately unbiased) p-value (percentage) for each 
branch of the tree was calculated and placed on a branch of a cluster dendro-
gram. If a branch had a value >99, we considered that cluster of samples as 
significantly separated from the other samples (Fig. 6 A). Memory B cell–
specific genes were identified with two distinct statistical methods (Fig. S3), 
Tukey’s multiple comparison test and ROKU, a tissue-specific gene identifi-
cation method (Kadota et al., 2006). If both methods labeled a specific gene 
as highly expressed in memory B cells, that gene is considered as a memory-
specific gene.
qRT-PCR analysis. Total RNA was purified from B cell subsets and 
cDNAs were synthesized using a SuperScript First-Strand Synthesis Sys-
tem for RT-PCR (Invitrogen) according to the manufacturer’s instruction. 
qRT-PCR was performed in triplicate with Platinum SYBR Green qPCR 
SuperMix-UDG (Invitrogen) using an ABI Prism7500 instrument (Applied 
Biosystems). Standard curves were created by serial dilution of cDNA syn-
thesized from naive splenocytes. The mRNA level for each gene was normal-
ized to the expression of -actin mRNA. PCR conditions were as follows: 
50°C for 2 min, 95°C for 2 min, 40 cycles of 95°C for 15 s, 60°C for 45 s, 
and NK1.1, followed by staining with anti-B220PE-Cy7, anti-IgMFITC, anti-
AA4.1APC,  anti-CD24PacificBlue,  anti-CD43PE,  and  streptavidinPE-TexasRed  for 
FACS analysis. BM B220+ cells were separated into AA4.1+ and AA4.1 cells 
(immature and mature B cell populations, respectively; Allman et al., 2001) 
by FACS and the frequency of prepro–B cells (CD24lowCD43hi), pro–B cells 
(CD24intCD43int), pre–B cells (CD24hiCD43lo), and IgM+ cells in immature 
(AA4.1+B220+) and mature B cell populations (AA4.1B220+) was analyzed 
(Nagaoka et al., 2000).
Analysis of FO and MZ B cells. Splenocytes from unimmunized mice 
were incubated with biotinylated mAbs against CD95, CD138, CD43, CD3, 
CD5, CD90, TER119, Gr-1, CD11b, DX5, and NK1.1, followed by staining 
with B220PE-Cy7, CD21FITC, AA4.1APC, and IgMPacificBlue streptavidinPE-TexasRed. 
Viable B220+AA4.1 cells were separated into FO (IgMintCD21int) and MZ 
(IgMhighCD21high) B cells.
Analysis of Tfh cells in mice with conditional Bcl6 deletion through 
CD4-cre. Splenocytes from NP-CG immunized mice were stained with 
anti-CXCR5APC (BD), anti-PD1PE (BioLegend), anti–TCR-PacificBlue (Bio-
Legend), anti-B220PE-Cy7, and anti-CD4FITC (BD). Viable B220TCR+CD4+ 
T cells were analyzed for CXCR5 and PD1 expression by FACS.
Cell purification. To purify memory and GC B cells, splenocytes from NP-
CG immunized mice were incubated with a mixture of biotinylated mAbs as 
described in Flow cytometric analysis for memory and GC B cells, followed 
by incubation with streptavidin microbeads (Miltenyi Biotec). Thereafter, 
the cells negatively selected by the MACS system (Miltenyi Biotec) were 
stained with anti-CD38AlexaFluor647, anti-B220PE-Cy7, anti-IgG1PacificBlue, PNAFITC, 
NIP-BSAPE, and streptavidinPE-TexasRed. In single cell sorting for VH sequence 
analysis, biotinylated anti-Ig (BD) was added into a mixture of biotinylated 
mAbs or anti-IgFITC (BD) was used instead of PNAFITC. To purify plasma 
cells, splenocytes from NP-CG immunized mice were incubated with a bio-
tinylated Ab cocktail and streptavidin microbeads. Thereafter, the cells nega-
tively selected by the MACS system were stained with anti-CD138APC (BD), 
anti-B220PE-Cy7,  anti-IgG1PacificBlue,  anti-IgFITC,  NIP-BSAPE,  and  streptav-
idinPE-TexasRed. To purify FO and MZ naive B cells, splenocytes from unim-
munized mice were incubated with biotinylated mAbs against as described in 
Analysis of FO and MZ B cells, followed by incubation with streptavidin 
microbeads. Thereafter, the cells negatively selected by the MACS system were 
stained  with  B220PE-Cy7,  CD21FITC,  CD23PE, AA4.1APC,  and  streptav-
idinPE-TexasRed. Viable B220+AA4.1 cells were separated into CD21intCD23+ 
FO and CD21hiCD23 MZ B cells.
BrdU incorporation assay. Mice were injected intraperitoneally with 
0.6 mg BrdU (Sigma-Aldrich) twice per day from days 4 to 6 after immuni-
zation with NP-CG/alum. On days 7, 20, and 40 after immunization, 
NP-specific/B220+/IgG1+ memory B cells (CD38+/PNAlow) and GC B cells 
(CD38dull/PNAhigh) were purified under the exclusion of dead cells by FACS 
from the pooled spleens of immunized mice and then mounted on a glass 
slide, fixed, and stained with FITC-labeled anti-BrdU mAb or FITC-labeled 
isotype control mAb (BD) and DAPI, or biotinylated anti-BrdU mAb 
(Abcam), followed by staining with streptavidinAlexaFluor546 and DAPI. The fre-
quency of stained cells was determined by confocal microscopic inspection 
of >100 B220+ cells, as previously described (Kimoto et al., 1997; Takahashi 
et al., 2001; Toyama et al., 2002), and the data were expressed as percentage of 
B220+ cells that exhibited nuclear BrdU incorporation (SP2AOBS; Leica).
Cell cycle analysis of memory B cells. Splenocytes were prepared from 
conditional Bcl6-deficient mice and controls at days 7 and 40 after immuni-
zation and incubated with 10 µg/ml Hoechst 33342 solution (Dojindo) 
for 45 min at 37°C, followed by incubation with a mixture of biotinylated 
mAbs as described in Flow cytometric analysis for memory and GC B cells. 
Thereafter, the cells were stained with anti-B220PE-Cy7, anti-CD38AlexaFluor647, 
anti-IgG1FITC (BD), NIP-BSAPE, and streptavidinPE-TexasRed for FACS analy-
sis. For cell cycle analysis in memory and GC B cells in immunized WT JEM Vol. 209, No. 11 
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